Recent scams targeting the diabetes community Diabetes Australia does not allow technology companies to put our logos or names on their advertising
That is why 65 health organisations and experts have today written to the chancellor urging the government to protect, not weaken, evidence-based policies to improve the nations diet
Strelitz J, Lawlor ER, Wu Y, Estlin A, Nandakumar G, Ahern AL, et al
Routine Laboratory Monitoring: While semaglutide doesn't require specific blood test monitoring beyond standard diabetes care, informing your primary care physician ensures appropriate interpretation of glucose, HbA1c, and other metabolic parameters
This study is designed to find the appropriate therapeutic dose regimen for the Phase 3 clinical development program and to evaluate less frequent dosing schedules than those for existing anti-obesity treatments